Drug-penetration gradients associated with acquired drug resistance in patients with tuberculosis K Dheda, L Lenders, G Magombedze, S Srivastava, P Raj, E Arning, ... American journal of respiratory and critical care medicine 198 (9), 1208-1219, 2018 | 138 | 2018 |
Systematic review and meta-analyses of the effect of chemotherapy on pulmonary Mycobacterium abscessus outcomes and disease recurrence JG Pasipanodya, D Ogbonna, BE Ferro, G Magombedze, S Srivastava, ... Antimicrobial agents and chemotherapy 61 (11), 10.1128/aac. 01206-17, 2017 | 114 | 2017 |
Dynamic imaging in patients with tuberculosis reveals heterogeneous drug exposures in pulmonary lesions AA Ordonez, H Wang, G Magombedze, CA Ruiz-Bedoya, S Srivastava, ... Nature medicine 26 (4), 529-534, 2020 | 102 | 2020 |
Linezolid dose that maximizes sterilizing effect while minimizing toxicity and resistance emergence for tuberculosis S Srivastava, G Magombedze, T Koeuth, C Sherman, JG Pasipanodya, ... Antimicrobial agents and chemotherapy 61 (8), 10.1128/aac. 00751-17, 2017 | 102 | 2017 |
Cellular and population plasticity of helper CD4+ T cell responses G Magombedze, PBJ Reddy, S Eda, VV Ganusov Frontiers in physiology 4, 206, 2013 | 91 | 2013 |
Mathematical analysis of a two strain HIV/AIDS model with antiretroviral treatment CP Bhunu, W Garira, G Magombedze Acta biotheoretica 57, 361-381, 2009 | 82 | 2009 |
Ceftazidime-avibactam has potent sterilizing activity against highly drug-resistant tuberculosis D Deshpande, S Srivastava, M Chapagain, G Magombedze, KR Martin, ... Science Advances 3 (8), e1701102, 2017 | 76 | 2017 |
Competition for antigen between Th1 and Th2 responses determines the timing of the immune response switch during Mycobaterium avium subspecies paratuberulosis infection in … G Magombedze, S Eda, VV Ganusov PLoS computational biology 10 (1), e1003414, 2014 | 65 | 2014 |
Evalution of the “iceberg phenomenon” in Johne's disease through mathematical modelling G Magombedze, CN Ngonghala, C Lanzas PloS one 8 (10), e76636, 2013 | 63 | 2013 |
Modelling the human immune response mechanisms to Mycobacterium tuberculosis infection in the lungs G Magombedze, W Garira, E Mwenje Mathematical Biosciences & Engineering 3 (4), 661-682, 2006 | 60 | 2006 |
Modelling the effects of pre-exposure and post-exposure vaccines in tuberculosis control CP Bhunu, W Garira, Z Mukandavire, G Magombedze Journal of theoretical biology 254 (3), 633-649, 2008 | 49 | 2008 |
Latent tuberculosis: models, computational efforts and the pathogen’s regulatory mechanisms during dormancy G Magombedze, D Dowdy, N Mulder Frontiers in bioengineering and biotechnology 1, 4, 2013 | 36 | 2013 |
Inferring biomarkers for Mycobacterium avium subsp. paratuberculosis infection and disease progression in cattle using experimental data G Magombedze, T Shiri, S Eda, JR Stabel Scientific Reports 7 (1), 44765, 2017 | 31 | 2017 |
A mathematical representation of the development of Mycobacterium tuberculosis active, latent and dormant stages G Magombedze, N Mulder Journal of Theoretical Biology, 2011 | 31 | 2011 |
Mathematical modelling of immune regulation of type 1 diabetes G Magombedze, P Nduru, CP Bhunu, S Mushayabasa Biosystems 102 (2-3), 88-98, 2010 | 31 | 2010 |
Modelling within host parasite dynamics of schistosomiasis ET Chiyaka, G Magombedze, L Mutimbu Computational and mathematical methods in medicine 11 (3), 255-280, 2010 | 29 | 2010 |
Spatial network mapping of pulmonary multidrug-resistant tuberculosis cavities using RNA sequencing K Dheda, L Lenders, S Srivastava, G Magombedze, H Wainwright, P Raj, ... American journal of respiratory and critical care medicine 200 (3), 370-380, 2019 | 27 | 2019 |
Predicting the Role of IL-10 in the Regulation of the Adaptive Immune Responses in Mycobacterium avium Subsp. paratuberculosis Infections Using Mathematical … G Magombedze, S Eda, J Stabel PloS one 10 (11), e0141539, 2015 | 26 | 2015 |
Transformation morphisms and time-to-extinction analysis that map therapy duration from preclinical models to patients with tuberculosis: translating from apples to oranges G Magombedze, JG Pasipanodya, S Srivastava, D Deshpande, ME Visser, ... Clinical Infectious Diseases 67 (suppl_3), S349-S358, 2018 | 25 | 2018 |
Optimal control of malaria chemotherapy G Magombedzea, C Chiyakab, Z Mukandavireb Nonlinear Anal. Modell. Contr 16 (4), 415-434, 2011 | 25 | 2011 |